Passa al contenuto
Merck
  • Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.

Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.

Contraception (1997-05-01)
F Z Stanczyk
PMID9220223
ABSTRACT

The purpose of the present report is to summarize the most important pharmacokinetic features of the new progestogens. In addition, the question of whether or not gestodene, in comparison to desogestrel, has an influence on the pharmacokinetics of ethinylestradiol (EE2) will be addressed.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto
E4876
Sigma-Aldrich
17α-Ethynylestradiol, ≥98%
PHR1480
Supelco
Ethinyl Estradiol, Pharmaceutical Secondary Standard; Certified Reference Material
1260001
USP
Ethinyl estradiol, United States Pharmacopeia (USP) Reference Standard
E1900000
Ethinylestradiol, European Pharmacopoeia (EP) Reference Standard
E-076
Supelco
17α-Ethynylestradiol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
SML0292
Sigma-Aldrich
Gestodene, ≥98% (HPLC)
Y0001124
Ethinylestradiol for system suitability, European Pharmacopoeia (EP) Reference Standard
Y0000509
Desogestrel, European Pharmacopoeia (EP) Reference Standard
Y0001112
Gestodene, European Pharmacopoeia (EP) Reference Standard
Y0000510
Desogestrel, European Pharmacopoeia (EP) Reference Standard